In a major crackdown since March this year, the drug regulators of seven states have alleged that 27 medicines — sold by 18 major drug companies in India including Abbott India, GSK India, Sun Pharma, Cipla and Glenmark Pharma — are of “substandard” quality, citing grounds such as false labelling, wrong quantity of ingredients, discolouration, moisture formation, failing dissolution test and failing disintegration test.
BMC Elections 2017: Shiv Sena Wins 84 Seats, BJP Closes Gap With 81 Seats
Police Deployment Outside Delhi’s Ramjas College Following Protests, Classes Suspended
BMC Polls: BJP Is Leading In Many Shiv Sena Pockets, Says Mumbai BJP Spokesperson Jiten Gajaria
BMC Elections 2017: Shiv Sena Leads In Mumbai, Thane; BJP Ahead In Pune, Nashik & Nagpur